Improving Perinatal Outcomes Among Kenyan Pregnant Women With an Integrated STI Testing Model
Launched by UNIVERSITY OF WASHINGTON · Jan 2, 2024
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how different methods of testing for sexually transmitted infections (STIs) can affect the health of pregnant women and their babies in Kenya. Researchers will compare three approaches: the usual care, which only treats symptoms without specific STI tests, testing all women for certain infections, and testing only those who show symptoms. A total of 3,132 pregnant women will participate and will be followed for up to nine months after giving birth to see how these testing methods impact outcomes like pregnancy loss, premature birth, and low birth weight.
To join the study, women must be seeking antenatal care at the clinic, plan to continue their care there, and be willing to undergo routine STI and HIV testing. Participants can expect to receive appropriate treatment if any STIs are found and will be closely monitored throughout their pregnancy and after delivery. This trial is important because it aims to improve the health of mothers and babies by finding the best way to manage STIs during pregnancy.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Self-identifying as a cisgender woman
- • Seeking antenatal services from the clinic
- • Planning to receive antenatal and postnatal care at the clinic
- • Willingness to receive syndromic STI screening and HIV/syphilis testing per national guidelines
- • Able and willing to provide informed consent for participation
- Exclusion Criteria:
- • Male gender
- • Not seeking antenatal services from the clinic
- • Not planning to receive antenatal and postnatal care at the clinic
- • Not willing to receive syndromic STI screening and HIV/syphilis testing per national guidelines
- • Not able or willing to provide informed consent for participation
About University Of Washington
The University of Washington (UW) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust network of interdisciplinary teams, UW fosters collaboration among top-tier researchers, clinicians, and healthcare professionals, aiming to translate scientific discoveries into impactful treatments and interventions. The university is dedicated to ethical research practices and participant safety, ensuring rigorous adherence to regulatory standards in all clinical trials. Through its state-of-the-art facilities and extensive expertise, UW strives to address pressing health challenges and improve patient outcomes on a local and global scale.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kisumu, , Kenya
Kisumu, , Kenya
Kisumu, , Kenya
Homa Bay, , Kenya
Homa Bay, , Kenya
Homa Bay, , Kenya
Kisumu, , Kenya
Yala, , Kenya
Patients applied
Trial Officials
Jillian Pintye, RN, MPH, PHD
Principal Investigator
University of Washington
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported